Seeking Alpha

Immucor, Inc. (BLUD)

BLUD is defunct.
  • Jul. 5, 2011, 10:16 AM
    TPG's acquisition of Immucor (BLUD +30%) fails to spur comparables Bio-Rad Laboratories (BIO -0.7%) and Gen-Probe (GPRO -1.1%). Takeout multiples were below current diagnostics multiples, Leerink notes, and the P-E buyout likely means there was little interest in BLUD from strategic acquirers.
    | Jul. 5, 2011, 10:16 AM | 1 Comment
  • Jul. 5, 2011, 8:05 AM
    Immucor (BLUD) to be acquired by TPG Capital for $27/share in cash ($1.97B). Immucor makes equipment used by blood banks, hospitals, and labs to test blood prior to transfusions. (PR) Good call by Andrew August back in March.
    | Jul. 5, 2011, 8:05 AM | 1 Comment
Company Description
Founded in 1982, Immucor, Inc., a Georgia corporation, develops, manufactures and sells a complete line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. Our offerings are targeted... More